Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80008 | 1.00 | CYP1A2 (0.39) | CYP1A2ALDH1A1KDM4ETDP1NPSR1 | |
| SCHEMBL27983235 | 0.88 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL28851752 | 0.87 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL27814124 | 0.80 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL28005450 | 0.78 | CYP1A2 (0.38) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL3804865 | 0.78 | CYP1A2 (0.38) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL3722471 | 0.77 | CYP1A2 (0.47) | CYP1A2ALDH1A1KDM4ETDP1 | |
| SCHEMBL7964537 | 0.75 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL8966109 | 0.75 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL28462121 | 0.72 | CYP1A2 (0.34) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584135-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-20230340495-A1 | APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS | COMPANY, THE P&G | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584135-B2 | Aptamers for personal health care applications | ICAM1, VCAM1, EPCAM | CYP1A2 4880/4885ALDH1A1 3663/4885KDM4E 2707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.